entertainment -WSS

entertainment

author：explore 2025-09-29 01:38:12 - browse：7

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： The CDC's new social media misinformation war

hotspot

WSS

Precocious puberty in girls comes with mental health risks

Amylyx ALS drug failure raises questions and concerns

A single Democrat is willing to weaken Medicare negotiation power

Adopting new red light myopia treatments may be short

In his State of the Union, Biden takes clear aim at 'Big Pharma'

The CDC's new social media misinformation war

Wikipedia

entertainment

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

The problem with charging patients to message their doctors

Hepatitis C has a cure — but many Americans still lack access to it

NEJM study link tiny plastics in blood vessels to heart problems

BioMarin wins approval for gene therapy to treat hemophilia A

Headspace, Meta partner to launch VR meditation app for Quest

State Dept. review finds Biden bears some blame for Afghanistan failures

Texas Medical Board asked to define abortion emergency exception

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Amgen, Regeneron, BGI Group and more

focus

A protest over insulin prices is seen as a fight for life

First medicine developed to treat MASH expected to be approved soon

IVF, abortion rights issues kick off Biden’s State of the Union

Amylyx ALS drug fails large clinical trial

Change Healthcare cyberattack prompts Medicare loan program

Bernie brings in new pharma CEOs to talk drug prices

entertainment

focus

hotspot

knowledge